Frk Eur Igc Etf (EURO) Share Price

PECC October 22-23 Optica Photonic-Enabled Cloud Computing Industry Summit hosted by Synopsis has a TOP SHELF speaker list, check it out here

https://www.optica.org/events/industry_events/2024/pecc/program_speakers/

Investors keep in mind that Synopsis has been posting

Yeah miserable chart.

>>> Sarepta Jumps on Broad Approval for Muscular Dystrophy Drug


Bloomberg

by Gerry Smith

Jun 20, 2024


https://finance.yahoo.com/news/sarepta-jumps-broad-approval-muscular-220459501.html


(Bloomberg) --

$HHSE NEWS: MINUTES OF THE BOARD OF DIRECTORS MEETING – June 11, 2024

Link to Minutes --> https://www.otcmarkets.com/otcapi/company/financial-report/405767/content MINUTES OF THE BOARD OF DIRECTORS MEETING – June 11, 2024

HANNOVER HOUSE, INC.

https://www.pacermonitor.com/public/case/51356241/PURDUE_PHARMA_LP_et_al_v_ELITE_LABORATORIES_INC,_et_al

Why would you look back. They need reimbursement to even sell this and no one knows what kind of revenue split they have with advent. There is no path to profitability in the UK. Let the dilution continue for perpetuity. This is a piggy bank/ATM for LP and cronies. ADVENT and annual salari

If there’s going to be a delay, we’ll see a notification early next week that both companies voted to do so.

Thanks Closet- sounds worse than I read originally.

The 13% vig is unbelievable. What do you suspect with the price action? I suspect it will hit around $.10 within the week but much depends on whether many longs accept the deal and exercise.

The company will be dumping

From Jim Sims - In general, we pass on the cost of our copper feedstock to customers, so it is typically a wash, even though it can increase topline revenue. We do benefit from higher copper pricing when we have lower-cost copper in inventory (lead-lag effect) but that can reverse at times.

So is being up 1000% with the money and balls to risk and be something.

Not some wannabe cool kid showing up with his chest out and false bravado who got no skin in the game and nothing in his pants

mri good

Part in which some have a bunch of outstanding shares to make it harder to buy up a bigger %

I looked at the chart again and think I misspoke in my reply to Marc. .0036 breaks its . 003 not .002. If .003 gives up then .0026 then it falls to the gap. I guess they can find support at any level though.
JMHO.
https://investorshub.advfn.com/uimage/uploads/2024/6/20/rslbp5EE03BDD-

Fellas… as much as it’s interesting to see the back and forth.. I think we just need to remain focused on the goal here and that’s the approval and accomplishing the goal., good luck all

I found a good one, finally. Hope to put some profits into BTC in the next year or so.

Glad to hear your crypto investments are working out.

Here we go again!

And the forget the dearly departed as of this afternoon.....Donald Sutherland (RIP)

Pretend judge cannon and the judge on the 11th circuit that is supporting her really really really really really really really really really really really really really really really really really really really really really really really really .......
needs to go.

So this company has a plan to develop a prototype or two? Is there anything else?

Grip - Per the math in the filing, each share is 7.9, which includes 1 warrant, another .2 shares and more than 13% cash to Paulson!

7.9 cents per unit!

Very reasonable approach.

But since you own it, why not own that own it and sit patiently. What do you get out of coming on a MB and whining like a little girl about it? Seriously, when you own something like this, gut it up while you hold it. I can never understand why investors tras

Is this Logan’s bro? On CIV&X

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174536983

You forgot revenues. Otherwise good summary

Just noise, imo....

[pre]
tim, last, bid, ask, volume

06/20/24 18:04:28 4.01 3.90 4.14 15
06/20/24 17:35:19 4.15 3.90 4.15 1,800
06/20/24 17:25:39 4.1479 3.90 4.15 800
06/20/24 16:37:57 4.15 3.90 4.15 500
06/20/24 16:30:44 3.85 3.82 4.

Keep your eye on insurance coverage and side effects of LLY and NVO meds for weight loss, as well as GILD’s presentation at ADA conference beginning tomorrow, 6/21/2024. I have stayed out of LLY and NVO while enjoying our substantial gain in 7,550 shares of NVDA (mentioned in your WSJ story link; I